Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryul Kim

Showing results (711-720 of 805) with videos related to

Pageof 81
Sort By:
Molecular Cancer|September 28, 2011
Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancerChang-Min Choi, Se-Jin Jang, Seong-Yeol Park, et al.
Malaria Journal|February 2, 2011
Detection of an antibody against Plasmodium vivax in residents of Gimpo-si, South Korea, using an indirect fluorescent antibody testWon-Ja Lee, Hyung-Hwan Kim, Soon-Mi Hwang, et al.
Scandinavian Journal of Gastroenterology|March 21, 2014
Prolonged N200 is the early neurophysiologic change in the patient with minimal hepatic encephalopathyJin-Hwa Moon, Dae Won Jun, Myung-Kul Yum, et al.
British Journal of Clinical Pharmacology|December 17, 2009
Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteersKyoung Soo Lim, Joo-Youn Cho, Bo-Hyung Kim, et al.
Ejhaem|April 10, 2026
Identification of an Elusive <i>CBFA2T3::GLIS2</i> Fusion Variant in Acute Megakaryoblastic Leukemia by Whole Genome SequencingYuna Lee, Jung Yoon Choi, Hyun Jin Park, et al.
BMB Reports|May 24, 2012
FGF-2 inhibits TNF-α mediated apoptosis through upregulation of Bcl2-A1 and Bcl-xL in ATDC5 cellsHey-Ryun Kim, Youn-Moo Heo, Kyoung-Il Jeong, et al.
Clinical Pharmacology and Therapeutics|August 4, 2004
Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic statesKyung-Sang Yu, Joo-Youn Cho, In-Jin Jang, et al.
Cancers|November 27, 2021
Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse ApproachHana Kim, Hyo Jung Kim, Hongsik Kim, et al.
BMC Cancer|February 18, 2016
Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective studyRyul Kim, Chan-Young Ock, Bhumsuk Keam, et al.
The Journal of Pathology|September 2, 2017
Genomic profiles of lung cancer associated with idiopathic pulmonary fibrosisJi An Hwang, Deokhoon Kim, Sung-Min Chun, et al.
Pageof 81

Showing results (711-720 of 805) with videos related to

Sort By:
Pageof 81
Molecular Cancer|September 28, 2011
Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancerChang-Min Choi, Se-Jin Jang, Seong-Yeol Park, et al.
Malaria Journal|February 2, 2011
Detection of an antibody against Plasmodium vivax in residents of Gimpo-si, South Korea, using an indirect fluorescent antibody testWon-Ja Lee, Hyung-Hwan Kim, Soon-Mi Hwang, et al.
Scandinavian Journal of Gastroenterology|March 21, 2014
Prolonged N200 is the early neurophysiologic change in the patient with minimal hepatic encephalopathyJin-Hwa Moon, Dae Won Jun, Myung-Kul Yum, et al.
British Journal of Clinical Pharmacology|December 17, 2009
Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteersKyoung Soo Lim, Joo-Youn Cho, Bo-Hyung Kim, et al.
Ejhaem|April 10, 2026
Identification of an Elusive <i>CBFA2T3::GLIS2</i> Fusion Variant in Acute Megakaryoblastic Leukemia by Whole Genome SequencingYuna Lee, Jung Yoon Choi, Hyun Jin Park, et al.
BMB Reports|May 24, 2012
FGF-2 inhibits TNF-α mediated apoptosis through upregulation of Bcl2-A1 and Bcl-xL in ATDC5 cellsHey-Ryun Kim, Youn-Moo Heo, Kyoung-Il Jeong, et al.
Clinical Pharmacology and Therapeutics|August 4, 2004
Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic statesKyung-Sang Yu, Joo-Youn Cho, In-Jin Jang, et al.
Cancers|November 27, 2021
Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse ApproachHana Kim, Hyo Jung Kim, Hongsik Kim, et al.
BMC Cancer|February 18, 2016
Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective studyRyul Kim, Chan-Young Ock, Bhumsuk Keam, et al.
The Journal of Pathology|September 2, 2017
Genomic profiles of lung cancer associated with idiopathic pulmonary fibrosisJi An Hwang, Deokhoon Kim, Sung-Min Chun, et al.
Pageof 81